DCAL.NS Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 05, 2026
Report Source: 2026 3rd Quarter Report
Dishman Carbogen Amcis Ltd. Stock Analysis DCAL.NS
Dishman Carbogen Amcis Ltd. is a manufacturing company, which engages in the provision of outsourcing services for the pharmaceutical industry. Its segments include CRAMS and Marketable Molecules. The CRAMS segment includes Contract Research Services and Contract Manufacturing Services, which it offers to its customers. Through its CRAMS business, the Company assists drug manufacturers in the development and optimization of processes for novel drug molecules in various stages of the development process. The Marketable Molecules segment manufactures and supplies intermediates, quaternary compounds, specialty chemicals, and various products for pharmaceuticals and cosmetics. The company has manufacturing and research facilities in India, Switzerland, France, the Netherlands, the United Kingdom, and China. Its subsidiaries include CARBOGEN AMCIS (Shanghai) Co. Ltd, Dishman Infrastructure Ltd., and others.
Read More Dishman Carbogen Amcis Ltd (DCAL.NS) Chart
Key Statistics of Dishman Carbogen Amcis Ltd (DCAL.NS)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
₹177.63Volume
2.96MP/E Ratio (TTM)
858.4452 Week Range
Market Cap
29.27BAvg. Volume
462.65KDividend Yield
-Financial Metrics & Statements of Dishman Carbogen Amcis Ltd (DCAL.NS)
FAQ's for Dishman Carbogen Amcis Ltd (DCAL.NS)
- According to Musaffa’s Shariah screening methodology, Dishman Carbogen Amcis Ltd (DCAL.NS) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.